Selective inhibition of phosphodiesterases 4A, B, C and D isoforms in chronic respiratory diseases: current and future evidences

S Contreras, J Milara, E Morcillo… - Current pharmaceutical …, 2017 - ingentaconnect.com
Chronic respiratory diseases affect millions of people every day. According to the World
Health Organization estimates,~ 235 million people suffer from asthma,~ 64 million suffer …
被引用次数：35 相关文章

Selective Inhibition of Phosphodiesterases 4A, B, C and D Isoforms in Chronic Respiratory Diseases: Current and Future Evidences

S Contreras, J Milara, E Morcillo… - Current …, 2017 - pubmed.ncbi.nlm.nih.gov
Chronic respiratory diseases affect millions of people every day. According to the World
Health Organization estimates,~ 235 million people suffer from asthma,~ 64 million suffer …

Selective Inhibition of Phosphodiesterases 4A, B, C and D Isoforms in Chronic Respiratory Diseases: Current and Future Evidences.

S Contreras, J Milara, E Morcillo… - Current Pharmaceutical …, 2017 - europepmc.org
Chronic respiratory diseases affect millions of people every day. According to the World
Health Organization estimates,~ 235 million people suffer from asthma,~ 64 million suffer …